Skip to content

Sam Cooper

Co-founder, PhenomicAI

Sam studied for his PhD at Imperial College London under Prof. Robert Glen –an early pioneer in cheminformatics and patent holder on a $6b drug, Zomig – as well as Dr. Chris Bakal – a leader in high content screening. Over this period, Sam worked to use novel machine learning approaches to answer questions in biology and drug discovery, publishing 12 times over 4 years and winning industry led competitions. He also met Oren Kraus, his co-founder at Phenomic AI, who was one of the first researchers to use deep-learning for analyzing biological data. Together they set-up Phenomic AI an early stage biotech that is racing to commercialize AI approaches for pharmaceutical R&D.